Comparison Summary Side-Effect Profile in Trials Reported side effects across all three compounds center on gastrointestinal events
Vomiting occurred in 5% and 9.2% versus 2.3%
Faraj M, Havel PJ, Phelis S, Blank D, Sniderman AD, Cianflone K
This is a transitional step ahead of the broader BALANCE model rollout in January 2027, which may expand coverage further
A Systematic Review and Meta-analysis of Randomized Controlled Trials of United States Food and Drug Administration-Approved, Home-use, Low-Level Light/Laser Therapy Devices for Pattern Hair Loss: Device Design and Technology
The remaining 1% consists of other peptide-related impurities, typically truncated sequences, deletion sequences, or oxidized forms of the target peptide